Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
cardiac event risk profile
.
Show all posts
Showing posts with label
cardiac event risk profile
.
Show all posts
Monday, April 11, 2016
Bosutinib shows 'low' vascular, cardiac event risk profile
›
In continuation of my update on Bosutinib Third-generation tyrosine kinase inhibitor (TKI) study findings suggest that bosutinib i...
›
Home
View web version
